Growth Metrics

Sarepta Therapeutics (SRPT) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 1.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.08%
Dec 31, 2025 50.67%
Sep 30, 2025 39.22%
Jun 30, 2025 80.81%
Mar 31, 2025 -79.32%
Dec 31, 2024 72.56%
Sep 30, 2024 17.15%
Jun 30, 2024 28.80%
Mar 31, 2024 -10.30%
Dec 31, 2023 32.09%
Sep 30, 2023 21.62%
Jun 30, 2023 -4.34%
Mar 31, 2023 -32.64%
Dec 31, 2022 17.38%
Sep 30, 2022 1.23%
Jun 30, 2022 5.43%
Mar 31, 2022 11.55%
Dec 31, 2021 37.89%
Sep 30, 2021 -3.14%
Jun 30, 2021 2.36%
Mar 31, 2021 -71.64%
Dec 31, 2020 -77.79%
Sep 30, 2020 -60.23%
Jun 30, 2020 -8.11%
Mar 31, 2020 134.19%
Dec 31, 2019 -26.33%
Sep 30, 2019 -3.62%
Jun 30, 2019 -22.21%
Mar 31, 2019 -34.06%
Dec 31, 2018 -57.60%
Sep 30, 2018 -34.75%
Jun 30, 2018 -60.18%
Mar 31, 2018 6.29%
Dec 31, 2017 -6.86%
Sep 30, 2017 -17.91%
Jun 30, 2017 -29.17%
Mar 31, 2017 -26.99%
Dec 31, 2016 -65.80%
Sep 30, 2016 -45.01%
Jun 30, 2016 -53.35%
Mar 31, 2016 -59.37%
Dec 31, 2015 -63.48%
Sep 30, 2015 -81.04%
Jun 30, 2015 -71.24%
Mar 31, 2015 -68.57%
Dec 31, 2014 -65.17%
Sep 30, 2014 -67.45%
Jun 30, 2014 -347.10%
Mar 31, 2014 -41.08%
Dec 31, 2013 -111.34%
Sep 30, 2013 -92.82%